EVAX
Price
$2.65
Change
-$0.01 (-0.38%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
16.8M
ORMP
Price
$2.13
Change
-$0.01 (-0.47%)
Updated
Jul 14, 12:32 PM (EDT)
Capitalization
87.22M
30 days until earnings call
Interact to see
Advertisement

EVAX vs ORMP

Header iconEVAX vs ORMP Comparison
Open Charts EVAX vs ORMPBanner chart's image
Evaxion A/S
Price$2.65
Change-$0.01 (-0.38%)
Volume$348
Capitalization16.8M
Oramed Pharmaceuticals
Price$2.13
Change-$0.01 (-0.47%)
Volume$1K
Capitalization87.22M
EVAX vs ORMP Comparison Chart in %
Loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVAX vs. ORMP commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (EVAX: $2.66 vs. ORMP: $2.13)
Brand notoriety: EVAX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 354% vs. ORMP: 25%
Market capitalization -- EVAX: $16.8M vs. ORMP: $87.22M
EVAX [@Biotechnology] is valued at $16.8M. ORMP’s [@Biotechnology] market capitalization is $87.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • EVAX’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • EVAX’s TA Score: 5 bullish, 3 bearish.
  • ORMP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, EVAX is a better buy in the short-term than ORMP.

Price Growth

EVAX (@Biotechnology) experienced а +11.30% price change this week, while ORMP (@Biotechnology) price change was -2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.17%. For the same industry, the average monthly price growth was +23.64%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

EVAX is expected to report earnings on May 27, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+13.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($87.2M) has a higher market cap than EVAX($16.8M). ORMP YTD gains are higher at: -11.777 vs. EVAX (-37.071). EVAX has higher annual earnings (EBITDA): -12.99M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. EVAX (17.8M). ORMP has less debt than EVAX: ORMP (301K) vs EVAX (10.5M). EVAX has higher revenues than ORMP: EVAX (3.29M) vs ORMP (2M).
EVAXORMPEVAX / ORMP
Capitalization16.8M87.2M19%
EBITDA-12.99M-21.53M60%
Gain YTD-37.071-11.777315%
P/E RatioN/A20.91-
Revenue3.29M2M165%
Total Cash17.8M131M14%
Total Debt10.5M301K3,488%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXORMP
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 18 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JSDA0.190.01
+2.78%
Jones Soda Co.
RUBSF31.25N/A
N/A
RUBIS
CSTUF11.48N/A
N/A
Constellation Acquisition Corp I
LSANF4.53-0.05
-1.09%
Los Andes Copper Ltd.
WPPGF5.87-0.17
-2.81%
WPP PLC

EVAX and

Correlation & Price change

A.I.dvisor tells us that EVAX and KURA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVAX and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+3.10%
KURA - EVAX
31%
Poorly correlated
+1.95%
LPTX - EVAX
30%
Poorly correlated
-7.12%
CRGX - EVAX
28%
Poorly correlated
-0.22%
HYPD - EVAX
27%
Poorly correlated
+5.08%
KYTX - EVAX
27%
Poorly correlated
+12.61%
More